New Products

TORONTO — Little Seashell, a Canada-based designer and manufacturer of greeting cards, announced its summer 2014 collection, which includes three vibrant designs.
 

NEW YORK — Duane Reade on Tuesday released the first update to its app for iPhone including the integration of iBeacon for 10-select Duane Reade locations active as of May 1. 

NORTHFIELD, Ill. — Planters, a brand from Kraft Foods Group, introduced four new peanut flavors to its product lineup. Consumers can now choose from Salted Caramel, Cocoa, Chipotle and Smoked flavors.

The brand incorporated both culinary trends and fan feedback when developing the new varieties, which pack up to 7 g of protein and at least four essential nutrients per serving.

NEW YORK — Pfizer's Nexium 24HR will launch May 27, Pfizer reported in a conference call Monday. 

"[The Nexium] approval represents the first significant milestone in executing our Rx-to-OTC strategy," reported Albert Bouria, Pfizer president of vaccines, oncology and consumer. 

The Food and Drug Administration in March approved over-the-counter Nexium 24HR (esomeprazole 20mg). In 2012, Pfizer acquired exclusive global rights from AstraZeneca to market non-prescription Nexium.

WILMINGTON, Del. — AstraZeneca on Tuesday announced the Food and Drug Administration approved Epanova (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL).

LENOIR, N.C. — Greer Labs announced the launch and commmercial availability of Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass mixed pollens allergen extract) sublingual allergy immunotherapy tablets. The drug is used for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis.

MOUNT PROSPECT, Ill. — C-Line Products, a developer and manufacturer or storage, protection and organization products, announced the debut of a new line of binder kits and accessories. The new product line offers a wide range of products and accessories for documents measuring 5 ½-inch by 8 ½-inch in size or smaller.

JERUSALEM — Teva Pharmaceutical Industries on Monday announced that the Food and Drug Administration approved Synribo (omacetaxine mepesuccinate) for injection, to include home administration. With the announcement of the approval, physicians who treat adults with chronic or accelerated phase CML (who are no longer responding to or can't tolerate  two or more tyrosine kinase inhibitors) now have the option to allow patients to administer Synribo at home.